CN108754276A - 一种医用纳米合金复合材料的制备方法 - Google Patents
一种医用纳米合金复合材料的制备方法 Download PDFInfo
- Publication number
- CN108754276A CN108754276A CN201810546207.7A CN201810546207A CN108754276A CN 108754276 A CN108754276 A CN 108754276A CN 201810546207 A CN201810546207 A CN 201810546207A CN 108754276 A CN108754276 A CN 108754276A
- Authority
- CN
- China
- Prior art keywords
- parts
- composite materials
- alloy composite
- preparation
- nano alloy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000956 alloy Substances 0.000 title claims abstract description 21
- 229910045601 alloy Inorganic materials 0.000 title claims abstract description 21
- 239000002131 composite material Substances 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004743 Polypropylene Substances 0.000 claims abstract description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 6
- KHYKFSXXGRUKRE-UHFFFAOYSA-J molybdenum(4+) tetracarbamodithioate Chemical compound C(N)([S-])=S.[Mo+4].C(N)([S-])=S.C(N)([S-])=S.C(N)([S-])=S KHYKFSXXGRUKRE-UHFFFAOYSA-J 0.000 claims abstract description 6
- 239000012188 paraffin wax Substances 0.000 claims abstract description 6
- 229920001155 polypropylene Polymers 0.000 claims abstract description 6
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910001950 potassium oxide Inorganic materials 0.000 claims abstract description 6
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 6
- 239000010936 titanium Substances 0.000 claims abstract description 6
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims abstract description 6
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 5
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910010271 silicon carbide Inorganic materials 0.000 claims abstract description 4
- 238000005245 sintering Methods 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 238000005496 tempering Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 4
- 150000002240 furans Chemical class 0.000 claims 1
- 229920000909 polytetrahydrofuran Polymers 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000007769 metal material Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- -1 ABS65 parts Chemical compound 0.000 description 1
- YWNYZQTZOONLGU-UHFFFAOYSA-N C(CC)Cl.[O] Chemical compound C(CC)Cl.[O] YWNYZQTZOONLGU-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229910003978 SiClx Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 150000001455 metallic ions Chemical class 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/04—Making non-ferrous alloys by powder metallurgy
- C22C1/05—Mixtures of metal powder with non-metallic powder
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C32/00—Non-ferrous alloys containing at least 5% by weight but less than 50% by weight of oxides, carbides, borides, nitrides, silicides or other metal compounds, e.g. oxynitrides, sulfides, whether added as such or formed in situ
- C22C32/0094—Non-ferrous alloys containing at least 5% by weight but less than 50% by weight of oxides, carbides, borides, nitrides, silicides or other metal compounds, e.g. oxynitrides, sulfides, whether added as such or formed in situ with organic materials as the main non-metallic constituent, e.g. resin
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/002—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working by rapid cooling or quenching; cooling agents used therefor
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/16—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of other metals or alloys based thereon
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种医用纳米合金复合材料的制备方法，由以下重量份的组分制得：钛粉40‑50份、无规共聚聚丙烯22‑25份、PBT40‑50份、二硫代氨基甲酸钼8‑10份、氧化硅20‑30份、ABS60‑65份、碳化硅3‑6份、磷酸三钠2‑4份、环氧氯丙烷3‑6份、聚四氢呋喃8‑23份、石墨烯3‑8份、氧化钾3‑6份、纳米银8‑20份、石蜡11‑15份。本发明方法制备得到的医用纳米合金复合材料具有较高的耐磨性以及优越的抗氧化性、抗菌性，制备工艺简单、加工成本低，生产过程安全环保，适合大规模的工业化生产。
Description
技术领域
本发明涉及一种医用纳米合金复合材料的制备方法。
背景技术
医用金属材料是用于生物医学材料的金属或合金，又称外科用金属材料，是一类惰性材料。此类材料具有高机械强度、抗疲劳和易加工等优良性能，是临床应用最广泛的承力植入材料。此类材料的应用非常广泛，涉及硬组织、软组织、人工器官和外科辅助器材等各个方面。医用金属材料经过多年的临床应用，仍然存在许多问题，除了医用材料常见的宿主反应以外，还由于金属腐蚀和磨损直接或间接造成的影响。医用金属材料中均含有较多的合金化元素．但它们在人体中所允许的浓度非常低。这些合金化元素多呈强的负电性，能够变化其电子价态并与生物体内的有机物或无机物质化合形成复杂的化台物（有些含有强烈的毒性）。另外，金属材料植入人体以后，由于腐蚀、磨损等导致金属离子溶出、金属；离子进入组织液里会引发某些生物反应，如组织反应．血液反应和全身反应，表现为水肿、血栓栓塞、感染及肿瘤等现象。
发明内容
本发明的目的在于提供一种医用纳米合金复合材料的制备方法。
为了实现上述目的，本发明提供了一种医用纳米合金复合材料的制备方法，该方法包括以下步骤：按重量份配比称取：钛粉40-50份、无规共聚聚丙烯22-25份、PBT40-50份、二硫代氨基甲酸钼8-10份、氧化硅20-30份、ABS60-65份、碳化硅3-6份、磷酸三钠2-4份、环氧氯丙烷3-6份、聚四氢呋喃8-23份、石墨烯3-8份、氧化钾3-6份、纳米银8-20份、石蜡11-15份；将各原料加入到混料机中进行混料，将混合均匀的混料加入到压力机设备中，进行加压成型，压力为 400-600MPa，保压 10-30min，然后将压制好的试样在烧结炉内进行烧结，预热温度为250-300℃，预热1-3h，烧结温度为1100-1400℃，烧结时间为10-30min，然后在250-350℃下保温10-20 min，淬灭，最后在150-180℃下保温回火1h，即可。
所述预热温度为280℃，预热时间为1.5h。
所述烧结温度为1200-1300℃，烧结时间为20min。
所述纳米银的粒径小于30纳米。
所述压力为500MPa。
有益效果：本发明方法制备得到的医用纳米合金复合材料具有较高的耐磨性以及优越的抗氧化性、抗菌性，制备工艺简单、加工成本低，生产过程安全环保，适合大规模的工业化生产。
具体实施方式
实施例1
一种医用纳米合金复合材料的制备方法，该方法包括以下步骤：按重量份配比称取：钛粉40份、无规共聚聚丙烯22份、PBT40份、二硫代氨基甲酸钼8份、氧化硅20份、ABS60份、碳化硅3份、磷酸三钠2份、环氧氯丙烷3份、聚四氢呋喃8份、石墨烯3份、氧化钾3份、纳米银8份、石蜡11份；将各原料加入到混料机中进行混料，将混合均匀的混料加入到压力机设备中，进行加压成型，压力为 400MPa，保压 10min，然后将压制好的试样在烧结炉内进行烧结，预热温度为250-300℃，预热1-3h，烧结温度为1100℃，烧结时间为10-30min，然后在250℃下保温10min，淬灭，最后在150-180℃下保温回火1h，即可。
所述纳米银的粒径小于30纳米。
实施例2
一种医用纳米合金复合材料的制备方法，该方法包括以下步骤：按重量份配比称取：钛粉50份、无规共聚聚丙烯25份、PBT50份、二硫代氨基甲酸钼10份、氧化硅30份、ABS65份、碳化硅6份、磷酸三钠4份、环氧氯丙烷6份、聚四氢呋喃23份、石墨烯8份、氧化钾6份、纳米银20份、石蜡15份；将各原料加入到混料机中进行混料，将混合均匀的混料加入到压力机设备中，进行加压成型，压力为 600MPa，保压 30min，然后将压制好的试样在烧结炉内进行烧结，预热温度为250-300℃，预热1-3h，烧结温度为1400℃，烧结时间为10min，然后在250-350℃下保温10-20 min，淬灭，最后在150-180℃下保温回火1h，即可。
所述纳米银的粒径小于30纳米。
实施例3
一种医用纳米合金复合材料的制备方法，该方法包括以下步骤：按重量份配比称取：钛粉40-50份、无规共聚聚丙烯22-25份、PBT40-50份、二硫代氨基甲酸钼8-10份、氧化硅20-30份、ABS60-65份、碳化硅3-6份、磷酸三钠2-4份、环氧氯丙烷3-6份、聚四氢呋喃8-23份、石墨烯3-8份、氧化钾3-6份、纳米银8-20份、石蜡11-15份；将各原料加入到混料机中进行混料，将混合均匀的混料加入到压力机设备中，进行加压成型，压力为500MPa，保压 10-30min，然后将压制好的试样在烧结炉内进行烧结，预热温度为280℃，预热1.5h，烧结温度为1250℃，烧结时间为20min，然后在250-350℃下保温10-20 min，淬灭，最后在150-180℃下保温回火1h，即可。
所述纳米银的粒径小于30纳米。
对实施例3制得医用纳米合金复合材料各个性能进行测试，医用纳米合金复合材料抗压强度最高可达到20.5MPa，具有很好的抗压效果，同时耐酸性、耐碱性达到了1000h以上无异常。
Claims (5)
1.一种医用纳米合金复合材料的制备方法，其特征在于该方法包括以下步骤：按重量份配比称取：钛粉40-50份、无规共聚聚丙烯22-25份、PBT40-50份、二硫代氨基甲酸钼8-10份、氧化硅20-30份、ABS60-65份、碳化硅3-6份、磷酸三钠2-4份、环氧氯丙烷3-6份、聚四氢呋喃8-23份、石墨烯3-8份、氧化钾3-6份、纳米银8-20份、石蜡11-15份；将各原料加入到混料机中进行混料，将混合均匀的混料加入到压力机设备中，进行加压成型，压力为 400-600MPa，保压 10-30min，然后将压制好的试样在烧结炉内进行烧结，预热温度为250-300℃，预热1-3h，烧结温度为1100-1400℃，烧结时间为10-30min，然后在250-350℃下保温10-20 min，淬灭，最后在150-180℃下保温回火1h，即可。
2.根据权利要求1所述的一种医用纳米合金复合材料的制备方法，其特征在于所述预热温度为280℃，预热时间为1.5h。
3.根据权利要求1所述的一种医用纳米合金复合材料的制备方法，其特征在于所述烧结温度为1200-1300℃，烧结时间为20min。
4.根据权利要求1所述的一种医用纳米合金复合材料的制备方法，其特征在于所述纳米银的粒径小于30纳米。
5.根据权利要求1所述的一种医用纳米合金复合材料的制备方法，其特征在于所述压力为500MPa。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810546207.7A CN108754276A (zh) | 2018-05-31 | 2018-05-31 | 一种医用纳米合金复合材料的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810546207.7A CN108754276A (zh) | 2018-05-31 | 2018-05-31 | 一种医用纳米合金复合材料的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108754276A true CN108754276A (zh) | 2018-11-06 |
Family
ID=64001075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810546207.7A Pending CN108754276A (zh) | 2018-05-31 | 2018-05-31 | 一种医用纳米合金复合材料的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108754276A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101107067A (zh) * | 2005-01-24 | 2008-01-16 | 金文申有限公司 | 含金属的复合材料 |
| WO2008048343A2 (en) * | 2006-02-14 | 2008-04-24 | Dynamet Technology, Inc. | Homogeneous titanium tungsten alloys produced by powder metal technology |
| CN106011587A (zh) * | 2016-07-22 | 2016-10-12 | 马建剑 | 一种耐腐蚀钛铝合金材料及其制备方法 |
| WO2017139078A1 (en) * | 2016-02-09 | 2017-08-17 | Nanotek Instruments, Inc. | Chemical-free production of graphene-reinforced inorganic matrix composites |
-
2018
- 2018-05-31 CN CN201810546207.7A patent/CN108754276A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101107067A (zh) * | 2005-01-24 | 2008-01-16 | 金文申有限公司 | 含金属的复合材料 |
| WO2008048343A2 (en) * | 2006-02-14 | 2008-04-24 | Dynamet Technology, Inc. | Homogeneous titanium tungsten alloys produced by powder metal technology |
| WO2017139078A1 (en) * | 2016-02-09 | 2017-08-17 | Nanotek Instruments, Inc. | Chemical-free production of graphene-reinforced inorganic matrix composites |
| CN106011587A (zh) * | 2016-07-22 | 2016-10-12 | 马建剑 | 一种耐腐蚀钛铝合金材料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1129731A2 (en) | Compositions, processes and methods of improving the wear resistance of prosthetic medical devices | |
| CN103028149B (zh) | 医用可降解Fe-Mg二元合金材料及其制备方法 | |
| CN103184369A (zh) | 一种β型Zr-Nb-Ti系生物医用合金及其制备方法 | |
| US20230303453A1 (en) | Crack self-healing functionally gradient material for ceramic cutting tools and preparation method thereof | |
| CN106726625A (zh) | 一种peek义齿牙复合材料及其制备方法 | |
| CN107986750A (zh) | 一种生物陶瓷材料及制备方法 | |
| CN110524000A (zh) | 一种3d打印医用钛合金粉末材料的制备方法 | |
| CN105256160B (zh) | 一种陶瓷基镍合金复合材料的3d打印方法 | |
| CN103028148A (zh) | 医用可降解Fe-Mg-X合金材料及其制备方法 | |
| CN107475564A (zh) | 一种高强致密钛合金‑陶瓷生物复合材料的制备方法 | |
| CN104446399B (zh) | 一种复合生物陶瓷材料及其制备方法 | |
| CN108754276A (zh) | 一种医用纳米合金复合材料的制备方法 | |
| CN104876584B (zh) | 一种硅化锆基复合陶瓷材料及其制备方法 | |
| CN107164704A (zh) | 一种多孔低模奥氏体不锈钢及其制备方法 | |
| CN104193378B (zh) | 改性碳纤维增强ha复合材料 | |
| CN103194648B (zh) | 一种高强度低模量的原位自生钛基复合材料及其制备方法 | |
| CN103526074A (zh) | 一种TiC颗粒增强Ti-Mo-Hf复合材料及制备方法 | |
| CN115821101B (zh) | 兼具高强度和抗菌特性的可降解锌基复合材料及制备方法 | |
| CN102634716B (zh) | 一种镁锌磷酸三钙复合材料的粉末热压烧结制备方法 | |
| CN111118338A (zh) | 一种硼化钛合金/羟基磷灰石复合材料的制备方法和应用 | |
| CN110123491A (zh) | 一种基于钛合金多孔骨架的人工髋臼内衬及其制作方法 | |
| CN113005330A (zh) | 一种生物可降解超细晶Zn-Li合金材料及制备方法与应用 | |
| CN112939594A (zh) | 一种新型骨肿瘤骨修复材料及其制备方法 | |
| CN104399115B (zh) | 用于种植牙的玻璃陶瓷及其制备方法 | |
| Muslim et al. | Study of the physical properties and biocompatibility assessments of low nickel stainless steel loaded with different graphene oxide content for safe biomedical applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181106 |